FIGURE 2
FROM:
IMP-3 is a novel progression marker in malignant melanoma
Jennifer G Pryor, Patricia A Bourne, Qi Yang, Betsy O Spaulding, Glynis A Scott and Haodong Xu
BACK TO ARTICLEFigure 2.

IMP-3 immunohistochemistry showing (a) weak cytoplasmic expression in the dermal component of a Spitz nevus and (b) strong cytoplasmic expression in metastatic melanoma. Compared to (c) patchy IMP-3 expression in a malignant melanoma with a Breslow depth
1 mm, (d) malignant melanoma with a Breslow depth >1 mm expresses IMP-3 in >90% of tumor cells. Note the IMP-3 expression in the hair follicle in part (c) (original magnification
400: a, b;
200: c, d).
